For Immediate Release
Laura Howell, Marketing Communications Coordinator
402-691-7479 │ This email address is being protected from spambots. You need JavaScript enabled to view it.
May 10, 2017
Streck signs distribution agreement with Genomax Technologies
Streck, Inc. and Genomax Technologies, a life sciences products distributor in Singapore, Malaysia and Thailand, have signed a distribution agreement for Streck’s cell stabilization and molecular products.
Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCT®, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; and Cell-Free RNA BCT®, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage.
Streck’s Molecular Products division is focused on the generation of rapid diagnostic tools that impact healthcare decisions. Streck’s molecular product line includes the ARM-D® Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the soon-to-launch rapid real-time PCR instrument, the Zulu RT™, capable of 40 cycle reactions in 20 minutes or less. In addition, Streck is developing a library of diagnostics tools that will soon be available in Singapore, Malaysia and the rest of the world.
“Streck’s cell stabilization products are the gold standard and market leader for cell-free applications, “ said Linsheng Wong, Managing Director at Genomax Technologies. “We are delighted to represent Streck in Singapore, Malaysia and Thailand to enable clinicians and life science researchers to conveniently access Streck’s cell stabilization products. In addition, Streck’s innovative molecular products will help to address the needs of clinical laboratories for rapid and robust molecular diagnostics assay.”
About Genomax Technologies
Genomax Technologies was founded in 2003 by a team of enterprising professionals with years of experience in life science and clinical products. Genomax Technologies’ core products cover five major categories of applications: bioinformatics, clinical, genomics, molecular cell biology and proteomics. We have local offices in Singapore, Malaysia and Thailand. Genomax Technologies is committed to offer high quality products and services with excellent technical support, friendly customer service and fast delivery. For more information, visit www.genomaxtech.com.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck's passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry's leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.